PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29091211-0	2017	Influence of ABCB11 and HNF4alpha genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study.	daclatasvir	43-54	hepatocyte nuclear factor 4 alpha	Homo sapiens	24-33	
29091211-3	2017	Objectives: We investigated the association between daclatasvir plasma concentrations at 2 weeks and 1 month of therapy and genetic variants (SNPs) in genes encoding transporters and nuclear factors (ABCB1, ABCB11 and HNF4alpha).	daclatasvir	52-63	hepatocyte nuclear factor 4 alpha	Homo sapiens	218-227	
29091211-6	2017	HNF4alpha 975 C > G polymorphism was found to be associated with the daclatasvir plasma concentrations at 2 weeks (P = 0.009) and 1 month of therapy (P = 0.006).	daclatasvir	72-83	hepatocyte nuclear factor 4 alpha	Homo sapiens	0-9